PortfoliosLab logoPortfoliosLab logo
DOV vs. ABT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DOV vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dover Corporation (DOV) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DOV achieves a 5.30% return, which is significantly higher than ABT's -14.07% return. Over the past 10 years, DOV has outperformed ABT with an annualized return of 15.65%, while ABT has yielded a comparatively lower 10.97% annualized return.


DOV

1D
0.27%
1M
-5.78%
6M
2.04%
YTD
5.30%
1Y
14.14%
3Y*
13.33%
5Y*
5.43%
10Y*
15.65%
ALL TIME*
12.56%

ABT

1D
0.09%
1M
15.48%
6M
-1.99%
YTD
-14.07%
1Y
-14.30%
3Y*
0.59%
5Y*
-0.75%
10Y*
10.97%
ALL TIME*
12.78%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.15B$1.25B$1.20B
$321.12M$269.36M$226.69M

DOV vs. ABT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
DOV
Dover Corporation
5.30%5.24%23.35%15.22%-24.34%45.73%11.53%65.80%-11.11%37.68%
ABT
Abbott Laboratories
-14.07%12.87%4.81%2.26%-20.68%30.53%28.04%22.08%29.06%52.03%

Correlation

The correlation between DOV and ABT is 0.10, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.10

Correlation (3Y)
Balances recent behavior with more history.

0.18

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.33

Correlation (10Y)
Provides a long-term view across more market conditions.

0.34

Correlation (All Time)
Calculated using the full available price history since Jul 1, 1985

0.28

The correlation between DOV and ABT shifts across timeframes, from 0.10 (1 year) to 0.34 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

DOV:

$27.56B

ABT:

$184.11B

EPS

DOV:

$8.29

ABT:

$3.11

PE Ratio

DOV:

24.68

ABT:

34.03

PEG Ratio

DOV:

1.02

ABT:

2.12

PS Ratio

DOV:

3.33

ABT:

3.96

PB Ratio

DOV:

3.60

ABT:

2.82

Total Revenue (TTM)

DOV:

$8.42B

ABT:

$46.59B

Gross Profit (TTM)

DOV:

$3.33B

ABT:

$26.46B

EBITDA (TTM)

DOV:

$1.80B

ABT:

$9.94B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DOV vs. ABT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

DOV
DOV Risk / Return Rank: 6262
Overall Rank
DOV Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
DOV Sortino Ratio Rank: 5858
Sortino Ratio Rank
DOV Omega Ratio Rank: 5656
Omega Ratio Rank
DOV Calmar Ratio Rank: 6666
Calmar Ratio Rank
DOV Martin Ratio Rank: 6767
Martin Ratio Rank

ABT
ABT Risk / Return Rank: 2424
Overall Rank
ABT Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
ABT Sortino Ratio Rank: 1919
Sortino Ratio Rank
ABT Omega Ratio Rank: 1919
Omega Ratio Rank
ABT Calmar Ratio Rank: 3232
Calmar Ratio Rank
ABT Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

DOV vs. ABT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dover Corporation (DOV) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DOVABTDifference
Sharpe ratioReturn per unit of total volatility

+1.08

Sortino ratioReturn per unit of downside risk

+1.59

Omega ratioGain probability vs. loss probability

1.11

0.92

+0.19

Calmar ratioReturn relative to maximum drawdown

0.96

-0.37

+1.33

Martin ratioReturn relative to average drawdown

2.31

-0.71

+3.02

DOV vs. ABT - Sharpe Ratio Comparison

The current DOV Sharpe Ratio is 0.53, which is higher than the ABT Sharpe Ratio of -0.54. The chart below compares the historical Sharpe Ratios of DOV and ABT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DOV vs. ABT - Drawdown Comparison

The maximum DOV drawdown since its inception was -58.22%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for DOV and ABT.


Loading charts...

Drawdown Indicators


DOVABTDifference

Max Drawdown

Largest peak-to-trough decline

-58.22%

-45.66%

-12.56%

Max Drawdown (1Y)

Largest decline over 1 year

-14.82%

-38.61%

+23.79%

Max Drawdown (3Y)

Largest decline over 3 years

-26.59%

-39.64%

+13.05%

Max Drawdown (5Y)

Largest decline over 5 years

-35.56%

-39.64%

+4.08%

Max Drawdown (10Y)

Largest decline over 10 years

-45.24%

-39.64%

-5.60%

Current Drawdown

Current decline from peak

-11.88%

-22.17%

+10.29%

Average Drawdown

Average peak-to-trough decline

-13.12%

-10.90%

-2.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.15%

20.16%

-14.01%

Volatility

DOV vs. ABT - Volatility Comparison

The current volatility for Dover Corporation (DOV) is 10.94%, while Abbott Laboratories (ABT) has a volatility of 12.65%. This indicates that DOV experiences smaller price fluctuations and is considered to be less risky than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DOVABTDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.94%

12.65%

-1.71%

Volatility (6M)

Calculated over the trailing 6-month period

20.76%

21.13%

-0.37%

Volatility (1Y)

Calculated over the trailing 1-year period

26.65%

26.55%

+0.10%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.15%

22.89%

+2.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.84%

23.95%

+2.89%

Dividends

DOV vs. ABT - Dividend Comparison

DOV's dividend yield for the trailing twelve months is around 1.02%, less than ABT's 2.35% yield.


PositionTTM20252024202320222021202020192018201720162015
ABT
Abbott Laboratories
2.35%1.88%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%
DOV
Dover Corporation
1.02%1.06%1.09%1.32%1.48%1.10%1.56%1.68%2.55%1.80%2.30%2.67%

Financials

DOV vs. ABT - Financials Comparison

This section allows you to compare key financial metrics between Dover Corporation and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

DOV vs. ABT - Profitability Comparison

The chart below illustrates the profitability comparison between Dover Corporation and Abbott Laboratories over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

DOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Dover Corporation reported a gross profit of 880.61M and revenue of 2.19B. Therefore, the gross margin over that period was 40.2%.

ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Abbott Laboratories reported a gross profit of 7.30B and revenue of 12.59B. Therefore, the gross margin over that period was 58.0%.

DOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Dover Corporation reported an operating income of 391.79M and revenue of 2.19B, resulting in an operating margin of 17.9%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Abbott Laboratories reported an operating income of 1.78B and revenue of 12.59B, resulting in an operating margin of 14.2%.

DOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Dover Corporation reported a net income of 312.25M and revenue of 2.19B, resulting in a net margin of 14.3%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Abbott Laboratories reported a net income of 928.00M and revenue of 12.59B, resulting in a net margin of 7.4%.


Frequently Asked Questions


DOV and ABT have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABT has higher volatility (12.65%) compared to DOV (10.94%). In terms of maximum drawdown, DOV dropped -58.22% vs ABT's -45.66%.

DOV currently has the higher Sharpe Ratio (0.53 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DOV and ABT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer